Sanofi (NYSE: SNY) reported Q2 EPS of EUR1.84, EUR0.14 better than the analyst estimate of EUR1.70. Revenue for the quarter came in at EUR9.39 billion versus the consensus estimate of EUR9.26 billion.

For earnings history and earnings-related data on Sanofi (SNY) click here.